Ionis Pharmaceuticals(IONS) - 2024 Q3 - Earnings Call Presentation

Q3:24 Business Update and Financial Results November 6, 2024 Nasdaq: IONS On Today's Earnings Call 2 Brett Monia, Ph.D. Chief Executive Officer Eugene Schneider, M.D. Chief Clinical Development Officer Richard Geary, Ph.D. Chief Development Officer Kyle Jenne Chief Global Product Strategy Officer Beth Hougen Chief Financial Officer Eric Swayze, Ph.D. Executive Vice President, Research Jonathan Birchall Chief Commercial Officer Forward-Looking Statements 3 This presentation includes forward-looking statement ...